相关实验视频
Updated: Apr 13, 2026

10:45
Genomic Transformation of the Picoeukaryote Ostreococcus tauri
Published on: July 13, 2012
16.1K
优化异质蛋白质生产过程使用基因工程Ogataea minuta向工业规模制造的优化
Masashi Tsuda1, Yuki Nakatani1, Satoshi Baba2
1Biologics Technology Research Laboratories 1, Daiichi Sankyo Co., Ltd., Chiyoda, Gunma 370-0503, Japan.
Journal of bioscience and bioengineering
|September 9, 2025
概括
经过改造以缺乏特定蛋白酶的Ogataea minuta酵母,可以有效地产生人体血清白蛋白和生物蛋白质. 这种优化的系统表明了大规模异质蛋白质生产的潜力.
科学领域:
- 生物技术是生物技术.
- 微生物工程 微生物工程
- 蛋白质生产 蛋白质生产
背景情况:
- 甲基营养酵母Ogataea minuta是异质蛋白质生产的潜在宿主.
- 蛋白酶活性可以降低重组蛋白的产量.
- 优化发酵对于有效的蛋白质表达至关重要.
研究的目的:
- 开发一种工程化O. minuta菌株,用于增强异质蛋白质生产.
- 优化发酵条件以最大限度地提高蛋白质产量.
- 为了证明生物制造O. minuta系统的工业规模适用性.
主要方法:
- 产生一种双重突变的O. minuta缺乏Prb1蛋白酶和酒精氧化酶.
- 优化发酵参数,包括碳/和pH控制.
- 扩大4500升生物反应器的生产规模.
主要成果:
- 经过工程改造的O. minuta双突变体实现了大约7.5g/L的人类血清白蛋白产量.
- 优化的发酵条件显著增加了蛋白质的生产.
- 在工业规模上成功制造了利波卡林衍生物生物蛋白.
结论:
- 工程化O. minuta是一种强大的宿主,用于高产量的异质蛋白质生产.
- 开发的发酵策略对于大规模生物制造是有效的.
- 这种基于O. minuta的系统显示出对工业蛋白质生产应用的重大前景.
相关概念视频
Bioreactor Controls-III
55
Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
55
Upstream Processing
87
Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
87
Production of Pharmaceuticals
70
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under...
70

